Tata Elxsi Launches a Global Technology Centre for Medical Devices from Bayer

Pune:  Tata Elxsi, a global leader in design and technology services, today announced the inauguration of the ‘Bayer Development Centre in Radiology’ at Tata Elxsi, Pune, India. The centre is designed to co-develop with Bayer, a leader in key areas of Radiology, advanced radiology devices and technology that enable early and accurate diagnosis and treatment of critical illnesses, supporting Bayer’s global mission to bring innovative, safe, and compliant solutions to patients and clinical staff worldwide.

This centre will provide a wide range of engineering for complex radiology devices, with an initial focus on Molecular Imaging. The facility’s integrated approach, which combines design, development, and validation, the centre will help accelerate time-to-market, enhance cost efficiency, and help deliver new technology to market fast, efficiently, and at an optimized cost, while meeting highest regulatory compliance standards.

This collaboration leverages Tata Elxsi’s healthcare engineering expertise and the strength of the Tata and India ecosystems—enabling access to advanced labs, regulatory partnerships, and specialised technology talent. This creates a scalable foundation for innovation and strengthens Bayer’s ability to deliver radiology solutions across multiple geographies, including the US and EU.

Dr. Konstanze Diefenbach, Head of Research & Development, Radiology, Bayer, commented: “Bayer is committed to innovative products and high-quality services in diagnostic imaging, and device innovation plays a critical role in delivering precision and safety in patient care. This new centre gives us direct access to specialised engineering capabilities through Tata Elxsi, enabling us to accelerate our pipeline of advanced radiology devices while maintaining the quality and reliability that healthcare providers expect from Bayer.”

Sreevatsa Sahasranaman, Sr. Vice President & Head – Healthcare & Life Sciences, Tata Elxsi, said, “This centre is more than an engineering hub—it is where Bayer’s radiology vision meets Tata Elxsi’s design, AI/ML, and regulatory expertise. Our teams will work together to translate ideas into devices that address real-world diagnostic challenges, with the assurance of safety, compliance, and global scalability.”

Related Posts

After two years, pharma volumes pick up pace

NEW DELHI: The domestic pharmaceutical retail market is showing its strongest signs yet of a shift from price-led to demand-led growth. Volume growth crossed 3% in June, the first time…

NPPA fixes prices of 39 drugs, raises anti-rabies immunoglobulin rate

The National Pharmaceutical Pricing Authority (NPPA) has allowed an increase in the retail price of anti-rabies immunoglobulin while fixing the retail prices of 39 drug formulations.  According to a gazette…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

After two years, pharma volumes pick up pace

After two years, pharma volumes pick up pace

NPPA fixes prices of 39 drugs, raises anti-rabies immunoglobulin rate

NPPA fixes prices of 39 drugs, raises anti-rabies immunoglobulin rate

Tambaram police arrest two persons after seizing 1,100 banned tablets, 5 kg ganja

Tambaram police arrest two persons after seizing 1,100 banned tablets, 5 kg ganja

Rajasthan Healthcare Crisis: 8 Mothers Die Post-C-Section

Rajasthan Healthcare Crisis: 8 Mothers Die Post-C-Section

Steroid cream misuse fuels spurt in fungal infections

Steroid cream misuse fuels spurt in fungal infections

Dr Reddy’s delays semaglutide supplies due to API issue

Dr Reddy’s delays semaglutide supplies due to API issue